相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
Bernhard Radlinger et al.
DIABETOLOGIA (2023)
Exercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats
Xudong Yang et al.
DIABETOLOGY & METABOLIC SYNDROME (2023)
Empagliflozin Enhances Autophagy, Mitochondrial Biogenesis, and Antioxidant Defense and Ameliorates Renal Ischemia/Reperfusion in Nondiabetic Rats
Moein Ala et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)
Disuse-associated loss of the protease LONP1 in muscle impairs mitochondrial function and causes reduced skeletal muscle mass and strength
Zhisheng Xu et al.
NATURE COMMUNICATIONS (2022)
SGLT2 Inhibitors and Ketone Metabolism in Heart Failure
Huitzilihuitl Saucedo-Orozco et al.
Journal of Lipid and Atherosclerosis (2022)
Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model
Ephraim B. Winzer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Excessive exercise training causes mitochondrial functional impairment and decreases glucose tolerance in healthy volunteers
Mikael Flockhart et al.
CELL METABOLISM (2021)
Lipids activate skeletal muscle mitochondrial fission and quality control networks to induce insulin resistance in humans
Christopher L. Axelrod et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL/6NCrl mice with high-fat diet/ streptozotocin-induced diabetes mellitus
Konstantin N. Belosludtsev et al.
MITOCHONDRION (2021)
Reduced metabolic capacity in fast and slow skeletal muscle via oxidative stress and the energy-sensing of AMPK/SIRT1 in malnutrition
Takumi Hirabayashi et al.
PHYSIOLOGICAL REPORTS (2021)
Combined effect of canagliflozin and exercise training on high-fat diet-fed mice
Kenichi Tanaka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure
Hideo Nambu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Insulin resistance and heart failure during treatment with sodium glucose cotransporter 2 inhibitors: proposed role of ketone utilization
Yoshiyuki Hattori
HEART FAILURE REVIEWS (2020)
Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 inhibitor use
Yuka Goto et al.
ENDOCRINE CONNECTIONS (2020)
Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway
Xiangyang Liu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy
Hitomi Otomo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad
Preethika Ekanayake et al.
CURRENT DIABETES REPORTS (2020)
SGLT2 Inhibitors Play a Salutary Role in Heart Failure via Modulation of the Mitochondrial Function
Yasuhiro Maejima
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway
Xuping Yang et al.
ADIPOCYTE (2020)
Effect of canagliflozin on the overall clinical state including insulin resistance in Japanese patients with type 2 diabetes mellitus
Yoko Koike et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Hydroxytyrosol influences exercise-induced mitochondrial respiratory complex assembly into supercomplexes in rats
Rafael A. Casuso et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
The combination of exercise training and sodium-glucose cotransporter-2 inhibition improves glucose tolerance and exercise capacity in a rodent model of type 2 diabetes
Melissa A. Linden et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Influence of Sodium Glucose Cotransporter 2 Inhibition on Physiological Adaptation to Endurance Exercise Training
Alissa A. Newman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury
Pongpan Tanajak et al.
JOURNAL OF ENDOCRINOLOGY (2018)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
AMPK in skeletal muscle function and metabolism
Rasmus Kjobsted et al.
FASEB JOURNAL (2018)
Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
Hao Zhou et al.
REDOX BIOLOGY (2018)
The 1-Week and 8-Month Effects of a Ketogenic Diet or Ketone Salt Supplementation on Multi-Organ Markers of Oxidative Stress and Mitochondrial Function in Rats
Wesley C. Kephart et al.
NUTRIENTS (2017)
Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle
Tracy P. O'Brien et al.
DIABETES (2017)
Mitochondrial quality control in insulin resistance and diabetes
Jonathan Wanagat et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2016)
The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels
Simon A. Hawley et al.
DIABETES (2016)
Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice
Atsushi Obata et al.
ENDOCRINOLOGY (2016)
Mitochondrial Quality Control as a Therapeutic Target
Hagir B. Suliman et al.
PHARMACOLOGICAL REVIEWS (2016)
SGLT2 Inhibitors May Predispose to Ketoacidosis
Simeon I. Taylor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle
Kristin I. Stanford et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2014)
Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats
Melissa A. Linden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Retromer Binding to FAM21 and the WASH Complex Is Perturbed by the Parkinson Disease-Linked VPS35(D620N) Mutation
Ian J. McGough et al.
CURRENT BIOLOGY (2014)
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
J. Bolinder et al.
DIABETES OBESITY & METABOLISM (2014)
The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission
Ruchika Anand et al.
JOURNAL OF CELL BIOLOGY (2014)
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
Aurora Merovci et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
Jan Bolinder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Mitochondrial Fission Contributes to Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle
Huei-Fen Jheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects
Ele Ferrannini et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Antioxidant Supplementation Reduces Skeletal Muscle Mitochondrial Biogenesis
Natalie A. Strobel et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2011)
β-Hydroxybutyrate inhibits insulin-mediated glucose transport in mouse oxidative muscle
Takashi Yamada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Subjects With Early-Onset Type 2 Diabetes Show Defective Activation of the Skeletal Muscle PGC-1α/Mitofusin-2 Regulatory Pathway in Response to Physical Activity
Maria Isabel Hernandez-Alvarez et al.
DIABETES CARE (2010)
Pathogenesis of Insulin Resistance in Skeletal Muscle
Muhammad A. Abdul-Ghani et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
SGLT2 inhibition - a novel strategy for diabetes treatment
Edward C. Chao et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Antioxidants prevent health-promoting effects of physical exercise in humans
Michael Ristow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Insulin-resistant muscle is exercise resistant: evidence for reduced response of nuclear-encoded mitochondrial genes to exercise
Elena De Filippis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise
H. Yokoyama et al.
DIABETES OBESITY & METABOLISM (2008)
The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model
Ming Zhang et al.
EXPERIMENTAL DIABETES RESEARCH (2008)
Maximal exercise test is a useful method for physical capacity and oxygen consumption determination in streptozotocin-diabetic rats
Bruno Rodrigues et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Lipolysis and fatty acid metabolism in men and women during the postexercise recovery period
Gregory C. Henderson et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Use and abuse of HOMA modeling
TM Wallace et al.
DIABETES CARE (2004)
A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes
S Kashyap et al.
DIABETES (2003)
分享论文
